Total cases 28
Age (years) Mean ± SD Median (range) 8.79 ± 5.03 7 (3.5-18)
Gender, n (%) Male Female 15 (53.6%) 13 (46.4%)
Underlying disease, n (%) ALL AML 19 (67.9%) 9 (32.1%)
Status of underlying disease, n (%) Remission Relaps 7 (25%) 21 (75%)
Prophylactic agent before IFI onset, n (%) Flucanazole Voriconazole 26 (92.8%) 2 (7.2%)
Prophylaxis duration before IFI episodes (days) Mean ± SD (range)
47 ± 24.04 (30-84)
Duration of neutropenia at IFI onset (days)* Mean ± SD (range) in ALL in AML 42.87 ± 35.5 (7-140) 42.18 ± 40.1 (7-140) 44.75 ± 20 (20-64)
IFI classification, episode (%) Possible Probable Proven 26 (78.8%) 5 (15.1%) 2 (6.1%)